Atorvia Health Technologies
Company Details
Status: Private
Employees: 1-10
Location:
Kanata, Ontario, Canada
Type:
sample
Technology:
sample
sample
About: Atorvia is a pre-clinical stage biopharmaceutical company on a mission to transform outcomes for patients with organ failure, starting with the kidney. Headquartered in Ottawa, ON, Atorvia is advancing a pipeline of technologies that will disrupt the existing organ failure landscape and transform outcomes for patients.
Atorvia's lead program is focused on critical protein:protein interactions that trigger cell death and kidney failure. A first-in-class synthetic peptide therapeutic is in development with an initial indication in Acute Kidney Injury (AKI). AKI is a common and often fatal condition that leaves surviving patients with long term morbidities and can lead to chronic kidney disease, end stage renal disease, stroke & myocardial infarction. There is currently no treatment available.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Atorvia Health Technologies | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.